Efficacy and safety of oral branched-chain amino acid supplementation in patients undergoing interventions for hepatocellular carcinoma: a meta-analysis

Importance of branched-chain amino acids in patients with liver cirrhosis and advanced hepatocellular carcinoma receiving hepatic arterial infusion chemotherapy

(2014) Takenori Kanekawa et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Clinical Characteristics and Time Trends in Etiology of Hepatocellular Cancer in Germany

(2013) Kerstin Schütte et al.   DIGESTION

Effect of treatment with branched-chain amino acids during sorafenib therapy for unresectable hepatocellular carcinoma

(2013) Haruhiko Takeda et al.   HEPATOLOGY RESEARCH

Pre-, Peri-, and Postoperative Oral Administration of Branched-Chain Amino Acids for Primary Liver Cancer Patients for Hepatic Resection: A Systematic Review

(2013) Jianyuan Meng et al.   NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL

The Effect of Long-term Supplementation With Branched-chain Amino Acid Granules in Patients With Hepatitis C Virus-related Hepatocellular Carcinoma After Radiofrequency Thermal Ablation

(2012) Hiroki Nishikawa et al.   JOURNAL OF CLINICAL GASTROENTEROLOGY

Hepatocellular carcinoma

(2012) Alejandro Forner et al.   LANCET

Mini-Nutritional Assessment Predicts Functional Status and Quality of Life of Patients With Hepatocellular Carcinoma in Taiwan

(2012) Wei-Chung Hsu et al.   NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL

Oral supplementation of branched-chain amino acids reduces early recurrence after hepatic resection in patients with hepatocellular carcinoma: a prospective study

(2012) Kengo Ichikawa et al.   SURGERY TODAY

Effects of branched-chain amino acid-enriched nutrient for patients with hepatocellular carcinoma following radiofrequency ablation: A one-year prospective trial

(2010) Hidekatsu Kuroda et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Effects of branched-chain amino acids-enriched nutrient support for patients undergoing liver resection for hepatocellular carcinoma

(2008) Takehiro Okabayashi et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial

(2008) Ann-Lii Cheng et al.   LANCET ONCOLOGY